News
Needham Reiterates Hold on Vertex Pharmaceuticals
26 Jul 24
News, Reiteration, Analyst Ratings
TD Cowen Maintains Buy on Vertex Pharmaceuticals, Raises Price Target to $500
23 Jul 24
News, Price Target, Analyst Ratings
Here's How Much $100 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth Today
23 Jul 24
News, Trading Ideas
Cantor Fitzgerald Maintains Overweight on Vertex Pharmaceuticals, Raises Price Target to $480
22 Jul 24
News, Price Target, Analyst Ratings
HC Wainwright & Co. Maintains Buy on Vertex Pharmaceuticals, Raises Price Target to $500
19 Jul 24
News, Price Target, Analyst Ratings
Genomics Extends And Expansion Drug Discovery Collaboration With Vertex
16 Jul 24
Biotech, News, General
Health Canada Grants Marketing Authorization For TRIKAFTA For People With Cystic Fibrosis Aged 2 Years And Older With Certain Rare Mutations
15 Jul 24
Biotech, News, Global, General
Forecasting The Future: 13 Analyst Projections For Vertex Pharmaceuticals
11 Jul 24
Analyst Ratings
Morgan Stanley Maintains Equal-Weight on Vertex Pharmaceuticals, Raises Price Target to $455
11 Jul 24
News, Price Target, Analyst Ratings
Check Out What Whales Are Doing With VRTX
10 Jul 24
Options, Markets
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 20 Years
18 Jun 24
News, Trading Ideas
13 Analysts Have This To Say About Vertex Pharmaceuticals
17 Jun 24
Analyst Ratings
Argus Research Maintains Buy on Vertex Pharmaceuticals, Raises Price Target to $550
17 Jun 24
News, Price Target, Analyst Ratings
Nvidia, AbbVie, Vertex Pharmaceuticals And An Oil Giant: CNBC's 'Final Trades'
17 Jun 24
News, Markets, Media, Trading Ideas
Alphabet To Rally Over 28%? Here Are 10 Top Analyst Forecasts For Tuesday
11 Jun 24
News, Price Target, Markets, Analyst Ratings, Trading Ideas
RBC Capital Maintains Sector Perform on Vertex Pharmaceuticals, Lowers Price Target to $421
11 Jun 24
News, Price Target, Analyst Ratings
Arcturus' Inhaled mRNA Therapeutic In Cystic Fibrosis Study Highlights Potential Amid Competitive Landscape: Analyst
7 Jun 24
Analyst Color, Biotech, Equities, News, Health Care, Price Target, Reiteration, Analyst Ratings, Movers, Trading Ideas, General
Vertex To Present New Data Demonstrating Significant Benefits Of Treatment With TRIKAFTA At The ECFS 47th European Cystic Fibrosis Conference Held June 5-8, 2024
7 Jun 24
Biotech, News, General
$1000 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth This Much Today
5 Jun 24
News, Trading Ideas
RBC Capital Reiterates Sector Perform on Vertex Pharmaceuticals, Maintains $424 Price Target
4 Jun 24
News, Price Target, Reiteration, Analyst Ratings
Press releases
Citius Pharmaceuticals (CTXR) Eyes Breakthrough with Late-Stage Drug Pipeline Poised for Regulatory Approval
17 Jul 24
News, Press Releases
Genomics plc Announces New Extension and Expansion of Drug Discovery Collaboration with Vertex
16 Jul 24
Press Releases
Health Canada Grants Marketing Authorization for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for People With Cystic Fibrosis Aged 2 Years and Older With Certain Rare Mutations
15 Jul 24
Press Releases
Citius Pharmaceuticals (CTXR) Nears Key FDA Decisions and Launch Plans for 2024
11 Jul 24
News, Press Releases
FDA move illuminates key role of telomere targeting as a viable therapeutic strategy for cancer treatment
9 Jul 24
News, Press Releases
Actinium Pharmaceuticals (ATNM) Reveals Promising Results from SIERRA Trial at EHA Congress
17 Jun 24
News, Press Releases
Vertex Presents Positive Long-Term Data On CASGEVY™ (exagamglogene autotemcel) at the 2024 Annual European Hematology Association (EHA) Congress
14 Jun 24
Press Releases
Vertex Presents New Data at the European Cystic Fibrosis Conference Demonstrating Significant Benefits of Treatment with TRIKAFTA®
7 Jun 24
Press Releases
MAIA Biotechnology (MAIA): Pioneering New Frontiers in NSCLC Treatment with THIO
7 Jun 24
News, Press Releases
Groundbreaking Study by MAIA Biotechnology (NYSE: MAIA) Indicates Promising New Treatment for Advanced Lung Cancer
6 Jun 24
News, Press Releases
MAIA Biotechnology Inc (MAIA) Stock Surges as Company Prepares to Present Promising Data at BIO International Convention
31 May 24
News, Press Releases
Vertex to Participate in Upcoming June Investor Conferences
22 May 24
Press Releases
Jennifer Schneider Elected to Vertex Board of Directors
15 May 24
Press Releases
Alpine Immune Sciences Reports First Quarter 2024 Financial Results
9 May 24
Press Releases
Vertex Reports First Quarter 2024 Financial Results
6 May 24
Press Releases